A single dose of a Covid-19 vaccine triggers an immune response in around 70 per cent of patients with myeloma – suggesting that it does provide protection against the virus.

The number of scientists able to access labs dropped by almost 30 per cent when the latest coronavirus lockdown was announced, according to new data released by the ICR. Some 28% are therefore resorting to working in unsociable hours to keep their research going. The ICR is calling for financial support to avert a two-year delay in cancer research advances reaching patients.

A survey of more than 200 researchers details impact of the pandemic. The scientists estimate their own research has been put back by six months through loss of access to labs, facilities, trials and samples. But they feel science has now adapted to COVID-19 – and researchers believe donations and Government support could accelerate recovery.